Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Clinical trial NCT07631884 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07631884
Sponsor: Haihua Yuan
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Neoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm Locally Advanced Malignant Solid Neoplasm Unresectable Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm HER2 Expression Biliary Tract Neoplasms Endometrial Neoplasms Urothelial Carcinoma (UC)Pancreatic Neoplasms Colorectal Neoplasms

Start date: 2026-06-15
Primary completion: 2028-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.